Chu, L.-H.; Liao, C.-C.; Liew, P.-L.; Chen, C.-W.; Su, P.-H.; Wen, K.-C.; Lai, H.-C.; Huang, R.-L.; Chen, L.-Y.
Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis. Int. J. Mol. Sci. 2022, 23, 5973.
https://doi.org/10.3390/ijms23115973
AMA Style
Chu L-H, Liao C-C, Liew P-L, Chen C-W, Su P-H, Wen K-C, Lai H-C, Huang R-L, Chen L-Y.
Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis. International Journal of Molecular Sciences. 2022; 23(11):5973.
https://doi.org/10.3390/ijms23115973
Chicago/Turabian Style
Chu, Ling-Hui, Chi-Chun Liao, Phui-Ly Liew, Chien-Wen Chen, Po-Hsuan Su, Kuo-Chang Wen, Hung-Cheng Lai, Rui-Lan Huang, and Lin-Yu Chen.
2022. "Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis" International Journal of Molecular Sciences 23, no. 11: 5973.
https://doi.org/10.3390/ijms23115973
APA Style
Chu, L.-H., Liao, C.-C., Liew, P.-L., Chen, C.-W., Su, P.-H., Wen, K.-C., Lai, H.-C., Huang, R.-L., & Chen, L.-Y.
(2022). Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis. International Journal of Molecular Sciences, 23(11), 5973.
https://doi.org/10.3390/ijms23115973